Mandy Ladene Leach, PHARMD | |
805 Highway 278 E, Amory, MS 38821-5304 | |
(662) 256-9603 | |
(662) 256-8495 |
Full Name | Mandy Ladene Leach |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 805 Highway 278 E, Amory, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316558000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | E-11971 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mandy Ladene Leach, PHARMD 805 Highway 278 E, Amory, MS 38821-5304 Ph: (662) 256-9603 | Mandy Ladene Leach, PHARMD 805 Highway 278 E, Amory, MS 38821-5304 Ph: (662) 256-9603 |
News Archive
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.
According to a report published today, we must all share responsibility for preventing the spread of diseases such as swine flu, SARS, avian influenza, diarrhoeal and skin diseases, and even the common cold.
A study that looked at how people behave during pandemics has identified key demographic and psychological factors that may predict protective behaviours. The study is published online today, 30th January 2010, in the British Journal of Health Psychology.
A recent study led by researchers in Texas A&M University's department of nutrition and food science shows how a novel regulatory mechanism serves as an important biomarker for the development of diabetes, as well as a potential therapeutic target for its prevention.
Coventry Health Care, Inc. (NYSE: CVH) announced today that it has signed a definitive agreement to acquire Preferred Health Systems, Inc. ("PHS"), a wholly-owned subsidiary of Via Christi Health System, Inc.
› Verified 5 days ago
Amy H Burrell, RHP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1310 Short Dr, Amory, MS 38821 Phone: 662-257-4748 | |
Shelby Maxcy, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Highway 278 E, Amory, MS 38821 Phone: 662-256-2281 | |
Lauren Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Highway 278 E, Amory, MS 38821 Phone: 662-256-2281 | |
Laura Ann Summerford, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Highway 278 E, Amory, MS 38821 Phone: 662-256-2281 | |
Tanya Michelle Pearson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60379 Cotton Gin Port Rd Ste B, Amory, MS 38821 Phone: 662-256-8165 Fax: 662-256-8186 | |
Tiffany Medlock, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515 Highway 278 E, Amory, MS 38821 Phone: 662-256-1590 | |
Dennis Everett Mitchell, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Earl Frye Blvd, Amory, MS 38821 Phone: 662-257-1212 Fax: 662-257-1207 |